Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes. - Wikidata - wikimedia - TriplyDB

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

http://www.wikidata.org/entity/Q37606025

about

Impaired burrowing is the most prominent behavioral deficit of aging htau mice.Potential Neuroprotective Effects of Adiponectin in Alzheimer's Disease.Clinical trials: past, current, and future for atypical Parkinsonian syndromes.Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms.A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies.Loss of tau rescues inflammation-mediated neurodegeneration.Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.

P2860

Q37025330-38C3E4A5-31AA-45EA-88E6-43327D618B9F Q37729219-B0017E63-6A7C-403A-9E21-92FC96A34B10 Q38223118-D2E5C76E-B10E-404F-958D-F539E5D368B4 Q38253639-E1C4D1AD-BFF0-4608-9B6B-6F4E81883ADB Q39270980-DE48FCF7-A3A8-45ED-B327-8D5E4B81E7F7 Q41590526-410B3B8C-3E72-4B06-BE7E-76DCB09A0368 Q55353865-E45D247B-96D8-4884-8FF1-E494CB2A28B0

P2860

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

http://www.wikidata.org/entity/Q37606025

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

@en

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

@nl

type

label

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

@en

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

@nl

prefLabel

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

@en

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

@nl

P1433

Q37606025-3163ED1A-42B3-41A4-A0F4-BA9CF132D837

P1476

Q37606025-86D0F6AF-A0BD-4844-9AD7-91AD790E04F6

P2093

Q37606025-269E0C0E-2300-41F6-9B00-ECDE10B8E345

Q37606025-39F630F6-7AA0-4416-B3F2-3DA36B8CA311

Q37606025-CEE8B5F6-3CBC-46B8-AFF5-15B6661B22BB

P2860

Q37606025-06988845-66DF-4F08-B048-60B3F8B95309

Q37606025-0879F2AE-3136-4658-8A7D-D6A276B13742

Q37606025-0A625743-E6B5-4E70-BBA4-5D4AF9E317EF

Q37606025-13CC956F-D34C-4B13-A596-7EABE3CEFD8D

Q37606025-14F81D3D-109E-42F2-9B2D-1E06D97E21A0

Q37606025-17A6C1FC-B357-4C68-87C4-F7018B9E50A7

Q37606025-21A54163-08BE-46D4-9DB6-E71785669927

Q37606025-25D96E6D-3119-44D2-88BB-FC939AE93F32

Q37606025-2A2511B8-5583-4AEF-8141-952ACC1CCFB2

Q37606025-2B2C7FCE-4085-4669-8E04-6F470E25F0EF

P304

Q37606025-BEADAC78-EC4B-4B7B-9FB2-79CE465DF9CD

P31

Q37606025-DDFC807E-FCAB-4E01-8EDF-30DF085A3E3A

P356

Q37606025-29E56A72-B790-4404-AD44-010F75367D38

P407

Q37606025-E3983699-B4C0-4C72-844B-28FD71B20115

P433

Q37606025-56DC4772-28B5-465D-A486-2F92F1580D46

P478

Q37606025-14D6B92A-8B2E-41AC-B377-A0166F053584

P50

Q37606025-91439EB3-EB86-4F1D-AAD2-CFB39F3491CB

Q37606025-989CB040-A4A8-4BDB-83D2-9B64E4F94CD4

Q37606025-D69E73D7-5C78-4B36-9E31-43E406AADDAB

P577

Q37606025-60C02740-0E6F-4330-974D-796D1B51DC03

P5875

Q37606025-719FCD81-F4B7-4D77-8083-5D2340652A4C

P698

Q37606025-A525248A-D855-4883-A28C-25ED1BF8F3B5

P921

Q37606025-634E2517-066F-4118-AF68-36F30F241F17

P932

Q37606025-380F10A0-FC83-4729-AE86-10702E26F8AD

P356

J.AJPATH.2013.11.021

P1433

The American Journal of Pathology

P1476

Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.

@en

P2093

Frank M Laferla

http://www.w3.org/2001/XMLSchema#string

Serena Abbondante

http://www.w3.org/2001/XMLSchema#string

Tatiana Estrada-Hernandez

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's Disease

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

Critical nodes in signalling pathways: insights into insulin action

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

The glamour and gloom of glycogen synthase kinase-3

Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease

Activation of immediate early genes and memory formation.

P304

819-826

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2013.11.021

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P50

David Baglietto-Vargas

Rodrigo Medeiros

Carlos J Rodriguez-Ortiz

P577

2014-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259698470

http://www.w3.org/2001/XMLSchema#string

P698

24412516

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3936327

http://www.w3.org/2001/XMLSchema#string